drugset / Trial / NCT05115136

Using Doxepin for Urticaria

NCT05115136

RandomizedParallel-groupDouble-blindTreatment

Summary

Isolated urticaria in the emergency department is widely treated by physicians with histamine blocking agents such as diphenhydramine, cetirizine, and cimetidine. Doxepin is a tricyclic antidepressant that has been shown to have much higher concentrations of histamine blocking activity and therefore may be useful in treating urticaria. The purpose of this study is to compare the effectiveness of using doxepin verses a traditional medication, diphenhydramine (Benadryl), in the treatment of isolated urticaria in the emergency department.

Timeline

Start
2022-05-23
Primary completion
2023-01-31
Completion
2023-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diphenhydramine Unknown 50 mg Oral
Subject Doxepin Unknown 25 mg Oral

Indications